Alexa Semon

Alexa Semon

Auto-generated profile, based on publicly available information

Alexa Semon

Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
XLXin V. Li
Xin V. Li
ILIrina Leonardi
Irina Leonardi
GPGregory G. Putzel
Gregory G. Putzel
ASAlexa Semon
Alexa Semon
WFWilliam D. Fiers
William D. Fiers
IIIliyan D. Iliev
Iliyan D. Iliev

12 January 2018 in Science
Verified
Journal Article
Closed access
PDF file
ILIrina Leonardi
Irina Leonardi
XLXin Li
Xin Li
ASAlexa Semon
Alexa Semon
DLDalin Li
Dalin Li
IDItai Doron
Itai Doron
IIIliyan D. Iliev
Iliyan D. Iliev
Phagocytes patrol intestinal fungi: Maintaining a healthy balance of gut bacteria can promote good health. Leonardi et al. show that fungi can also interact with gut immune cells to maintain intestinal well-being. CX3CR1 + mononuclear phagocytes (MNPs) patrol the intestine and promote antifungal immunity. Genetic deletion of CX3CR1 in MNPs caused colitis-like symptoms in mice. CX3CR1 polymorphisms were detected in Crohn's disease patients that were unable to produce antibodies against multiple fungal species. Thus, commensal fungi may be as important as bacteria in maintaining gut health, and antifungal therapy could hold promise for treating intestinal inflammation. Science , this issue p. 232

5 February 2021 in Cell
Verified
Journal Article
Closed access
IDItai Doron
Itai Doron
ILIrina Leonardi
Irina Leonardi
XLXin V. Li
Xin V. Li
WFWilliam D. Fiers
William D. Fiers
ASAlexa Semon
Alexa Semon
IIIliyan D. Iliev
Iliyan D. Iliev

4 October 2024 in Science
Verified
Journal Article
Closed access
MAMohamad-Gabriel Alameh
Mohamad-Gabriel Alameh
ASAlexa Semon
Alexa Semon
NBNile U. Bayard
Nile U. Bayard
YPYi-Gen Pan
Yi-Gen Pan
GDGarima Dwivedi
Garima Dwivedi
JZJoseph P. Zackular
Joseph P. Zackular
Clostridioides difficile infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)–lipid nanoparticle (LNP) vaccine targeting C. difficile toxins and virulence factors. This multivalent vaccine elicited robust and long-lived systemic and mucosal antigen-specific humoral and cellular immune responses across animal models, independent of changes to the intestinal microbiota. Vaccination protected mice from lethal CDI in both primary and recurrent infection models, and inclusion of non-toxin cellular and spore antigens improved decolonization of toxigenic C. difficile from the gastrointestinal tract. Our studies demonstrate mRNA-LNP vaccine technology as a promising platform for the development of novel C. difficile therapeutics with potential for limiting acute disease and promoting bacterial decolonization.

20 July 2022 in Nature
Verified
Journal Article
Closed access
PDF file
XLXin V. Li
Xin V. Li
ILIrina Leonardi
Irina Leonardi
GPGregory G. Putzel
Gregory G. Putzel
ASAlexa Semon
Alexa Semon
WFWilliam D. Fiers
William D. Fiers
IIIliyan D. Iliev
Iliyan D. Iliev

3 September 2026 in Science
Verified
Journal Article
Closed access
ASAlexa Semon
Alexa Semon
HMHaider S. Manzer
Haider S. Manzer
OKOrlaith Keenan
Orlaith Keenan
TZTiffany H. Zhou
Tiffany H. Zhou
CTConnor Tiffany
Connor Tiffany
JZJoseph P. Zackular
Joseph P. Zackular
Clostridioides difficile causes severe disease in adults but commonly colonizes infants asymptomatically. The consequences of early-life colonization on host development remain unknown. In a neonatal mouse model, C. difficile colonization drove proinflammatory and tissue repair responses in the intestinal epithelium, enriching injury-associated intestinal stem cell populations and skewing differentiation toward secretory lineages. Despite transient colonization, exposure to C. difficile early in life led to persistent changes into adulthood. Epithelial responses were toxin dependent, as colonization with nontoxigenic strains or maternal vaccination with a C. difficile –targeted messenger RNA–lipid nanoparticle vaccine protected neonates. Human infant intestinal epithelial cells were sensitive to C. difficile toxins, and biopsies from colonized infants exhibited altered intestinal stem cell behavior. This study redefines C. difficile as an underappreciated early-life pathogen with lasting effects on host development.